PLC (NASDAQ:SMX; SMXWW), a leader in molecular marking and blockchain-backed digital infrastructure, today launched its Digital Material Passport Platform (DMPP), a new digital layer for the global ...

The rapid adoption of Generative AI Applications across enterprises has transformed productivity, automation, and decision-making. AI tools now power daily workflows by drafting emails, writing code, ...

Press Advantage, a leading press release distribution service, has released comprehensive educational resources explaining how press releases serve as critical tools for search engines to validate and ...

Cybersecurity researchers are calling attention to a new campaign dubbed JS#SMUGGLER that has been observed leveraging compromised websites as a distribution vector for a remote access trojan named ...

For IT professionals, SASE certifications can demonstrate hands-on experience with cloud-based network and security-as-a-service platforms. As cyberattacks grow more sophisticated and AI-powered ...

Naltrexone is a prescription medication used to manage both alcohol and opioid use disorders in adults. The typical oral dosage of naltrexone for alcohol use disorder is 50 milligrams (mg) daily. For ...

Forbes contributors publish independent expert analyses and insights. Aytekin Tank is the founder and CEO of Jotform. As a founder with a developer’s background, I never considered myself a marketing ...

Cybersecurity researchers are calling attention to a new type of credential phishing scheme that ensures that the stolen information is associated with valid online accounts. The technique has been ...

A year ago, I wrote a piece here about how people were really using gen AI. That article seemed to hit a note: It was popular, featured in viral posts, and the beautiful accompanying infographic has ...

According to McKinsey & Company, efficacy and scientific credibility are two of the most important factors consumers seek when selecting wellness products. Canomiks’ genomics and AI-based product and ...

New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine—a so-called "one and done" vaccine that confers lifetime immunity ...